Search - tctmd.com

Displaying 421 - 440 of 758

Sort: Relevancy | Date

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

Shelley Wood

June 30, 2021

News Industry News

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

June 29, 2021

News Daily News

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

Shelley Wood

June 11, 2021

News Daily News

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

L.A. McKeown

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Todd Neale

May 17, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News EHRA 2021

His-Bundle Pacing Gains Support in Pilot Study

Todd Neale

April 28, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

L.A. McKeown

March 25, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

Advertisement

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

June 2021 News Roundup

TCTMD’s Top 10 Most Popular Stories for May 2021

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

‘Enormous’ QoL Improvements With Mavacamten in HCM

May 2021 News Roundup

His-Bundle Pacing Gains Support in Pilot Study

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

April 2021 News Roundup

Roughly 80% of ESC Guideline Writers Have Financial COIs

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

Women Treated for Acute HF Report Worse QoL Than Men

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content